RESULTS	The intent-to-treat analysis showed at the endpoint an overall rate of 80 % of `` BZD discontinuation '' and of 35.4 % of `` BZD cessation without withdrawal '' in the total population ( no significant intergroup differences were observed on these rates ) .\